Go Pro

Rockwell Medical (RMTI) Competitors

Rockwell Medical logo
$0.59 -0.06 (-9.77%)
Closing price 04:00 PM Eastern
Extended Trading
$0.58 -0.01 (-1.60%)
As of 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

RMTI vs. ARAY, ABT, ISRG, SYK, and MDT

Should you buy Rockwell Medical stock or one of its competitors? MarketBeat compares Rockwell Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Rockwell Medical include Accuray (ARAY), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "health care equipment" industry.

How does Rockwell Medical compare to Accuray?

Rockwell Medical (NASDAQ:RMTI) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

Rockwell Medical has a beta of 1.58, meaning that its share price is 58% more volatile than the broader market. Comparatively, Accuray has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market.

Rockwell Medical has a net margin of -7.98% compared to Accuray's net margin of -10.76%. Rockwell Medical's return on equity of -15.41% beat Accuray's return on equity.

Company Net Margins Return on Equity Return on Assets
Rockwell Medical-7.98% -15.41% -9.62%
Accuray -10.76%-79.43%-10.38%

In the previous week, Rockwell Medical had 5 more articles in the media than Accuray. MarketBeat recorded 7 mentions for Rockwell Medical and 2 mentions for Accuray. Accuray's average media sentiment score of 1.40 beat Rockwell Medical's score of 0.19 indicating that Accuray is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rockwell Medical
0 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Accuray
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 64.1% of Accuray shares are owned by institutional investors. 4.6% of Rockwell Medical shares are owned by insiders. Comparatively, 4.4% of Accuray shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Rockwell Medical currently has a consensus price target of $2.00, indicating a potential upside of 240.48%. Accuray has a consensus price target of $2.00, indicating a potential upside of 670.12%. Given Accuray's higher possible upside, analysts clearly believe Accuray is more favorable than Rockwell Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rockwell Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Accuray
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Accuray has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Accuray, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rockwell Medical$69.26M0.33-$5.31M-$0.15N/A
Accuray$458.51M0.07-$1.59M-$0.37N/A

Summary

Rockwell Medical beats Accuray on 10 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Abbott Laboratories?

Rockwell Medical (NASDAQ:RMTI) and Abbott Laboratories (NYSE:ABT) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

Abbott Laboratories has a net margin of 13.90% compared to Rockwell Medical's net margin of -7.98%. Abbott Laboratories' return on equity of 17.62% beat Rockwell Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Rockwell Medical-7.98% -15.41% -9.62%
Abbott Laboratories 13.90%17.62%10.01%

Rockwell Medical has a beta of 1.58, suggesting that its share price is 58% more volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market.

In the previous week, Abbott Laboratories had 40 more articles in the media than Rockwell Medical. MarketBeat recorded 47 mentions for Abbott Laboratories and 7 mentions for Rockwell Medical. Abbott Laboratories' average media sentiment score of 0.94 beat Rockwell Medical's score of 0.19 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rockwell Medical
0 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Abbott Laboratories
33 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
4 Negative mention(s)
1 Very Negative mention(s)
Positive

Abbott Laboratories has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rockwell Medical$69.26M0.33-$5.31M-$0.15N/A
Abbott Laboratories$44.33B3.65$6.52B$3.5725.99

Rockwell Medical presently has a consensus target price of $2.00, suggesting a potential upside of 240.48%. Abbott Laboratories has a consensus target price of $118.30, suggesting a potential upside of 27.51%. Given Rockwell Medical's higher possible upside, analysts clearly believe Rockwell Medical is more favorable than Abbott Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rockwell Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Abbott Laboratories
1 Sell rating(s)
4 Hold rating(s)
19 Buy rating(s)
2 Strong Buy rating(s)
2.85

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 4.6% of Rockwell Medical shares are owned by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Abbott Laboratories beats Rockwell Medical on 14 of the 17 factors compared between the two stocks.

How does Rockwell Medical compare to Intuitive Surgical?

Rockwell Medical (NASDAQ:RMTI) and Intuitive Surgical (NASDAQ:ISRG) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, media sentiment, analyst recommendations, dividends and profitability.

Intuitive Surgical has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rockwell Medical$69.26M0.33-$5.31M-$0.15N/A
Intuitive Surgical$10.06B14.29$2.86B$8.2549.21

Intuitive Surgical has a net margin of 28.15% compared to Rockwell Medical's net margin of -7.98%. Intuitive Surgical's return on equity of 15.98% beat Rockwell Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Rockwell Medical-7.98% -15.41% -9.62%
Intuitive Surgical 28.15%15.98%14.07%

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are held by institutional investors. 4.6% of Rockwell Medical shares are held by company insiders. Comparatively, 0.6% of Intuitive Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Intuitive Surgical had 26 more articles in the media than Rockwell Medical. MarketBeat recorded 33 mentions for Intuitive Surgical and 7 mentions for Rockwell Medical. Intuitive Surgical's average media sentiment score of 1.12 beat Rockwell Medical's score of 0.19 indicating that Intuitive Surgical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rockwell Medical
0 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Intuitive Surgical
21 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Positive

Rockwell Medical presently has a consensus price target of $2.00, indicating a potential upside of 240.48%. Intuitive Surgical has a consensus price target of $573.42, indicating a potential upside of 41.25%. Given Rockwell Medical's higher possible upside, equities analysts clearly believe Rockwell Medical is more favorable than Intuitive Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rockwell Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Intuitive Surgical
1 Sell rating(s)
7 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.67

Rockwell Medical has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market. Comparatively, Intuitive Surgical has a beta of 1.46, suggesting that its stock price is 46% more volatile than the broader market.

Summary

Intuitive Surgical beats Rockwell Medical on 13 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Stryker?

Rockwell Medical (NASDAQ:RMTI) and Stryker (NYSE:SYK) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 77.1% of Stryker shares are owned by institutional investors. 4.6% of Rockwell Medical shares are owned by company insiders. Comparatively, 4.6% of Stryker shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Rockwell Medical has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market. Comparatively, Stryker has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

Stryker has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rockwell Medical$69.26M0.33-$5.31M-$0.15N/A
Stryker$25.27B5.01$3.25B$8.6438.23

Rockwell Medical currently has a consensus price target of $2.00, suggesting a potential upside of 240.48%. Stryker has a consensus price target of $395.33, suggesting a potential upside of 19.70%. Given Rockwell Medical's higher possible upside, research analysts clearly believe Rockwell Medical is more favorable than Stryker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rockwell Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Stryker
0 Sell rating(s)
6 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.73

Stryker has a net margin of 13.20% compared to Rockwell Medical's net margin of -7.98%. Stryker's return on equity of 23.42% beat Rockwell Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Rockwell Medical-7.98% -15.41% -9.62%
Stryker 13.20%23.42%11.04%

In the previous week, Stryker had 13 more articles in the media than Rockwell Medical. MarketBeat recorded 20 mentions for Stryker and 7 mentions for Rockwell Medical. Stryker's average media sentiment score of 1.17 beat Rockwell Medical's score of 0.19 indicating that Stryker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rockwell Medical
0 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Stryker
17 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Stryker beats Rockwell Medical on 13 of the 15 factors compared between the two stocks.

How does Rockwell Medical compare to Medtronic?

Rockwell Medical (NASDAQ:RMTI) and Medtronic (NYSE:MDT) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends and institutional ownership.

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 82.1% of Medtronic shares are held by institutional investors. 4.6% of Rockwell Medical shares are held by company insiders. Comparatively, 0.3% of Medtronic shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Rockwell Medical presently has a consensus target price of $2.00, suggesting a potential upside of 240.48%. Medtronic has a consensus target price of $99.00, suggesting a potential upside of 22.23%. Given Rockwell Medical's higher probable upside, equities analysts plainly believe Rockwell Medical is more favorable than Medtronic.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rockwell Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Medtronic
0 Sell rating(s)
11 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
2.61

In the previous week, Medtronic had 35 more articles in the media than Rockwell Medical. MarketBeat recorded 42 mentions for Medtronic and 7 mentions for Rockwell Medical. Medtronic's average media sentiment score of 1.21 beat Rockwell Medical's score of 0.19 indicating that Medtronic is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rockwell Medical
0 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Medtronic
30 Very Positive mention(s)
3 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Medtronic has a net margin of 13.20% compared to Rockwell Medical's net margin of -7.98%. Medtronic's return on equity of 14.51% beat Rockwell Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Rockwell Medical-7.98% -15.41% -9.62%
Medtronic 13.20%14.51%7.76%

Medtronic has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rockwell Medical$69.26M0.33-$5.31M-$0.15N/A
Medtronic$36.36B2.85$4.80B$3.7321.71

Rockwell Medical has a beta of 1.58, suggesting that its share price is 58% more volatile than the broader market. Comparatively, Medtronic has a beta of 0.58, suggesting that its share price is 42% less volatile than the broader market.

Summary

Medtronic beats Rockwell Medical on 13 of the 16 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RMTI vs. The Competition

MetricRockwell MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$23.19M$8.40B$6.84B$12.44B
Dividend YieldN/A2.47%2.67%6.11%
P/E Ratio-3.9216.2625.8324.36
Price / Sales0.335.75541.5496.87
Price / CashN/A18.0729.0936.93
Price / Book0.623.4610.986.49
Net Income-$5.31M$226.25M$3.57B$336.61M
7 Day Performance-12.22%2.48%3.06%0.90%
1 Month Performance-21.00%-2.95%0.72%-0.36%
1 Year Performance-25.84%1.11%36.82%31.26%

Rockwell Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMTI
Rockwell Medical
2.7455 of 5 stars
$0.59
-9.8%
$2.00
+240.5%
-17.8%$23.19M$69.26MN/A300
ARAY
Accuray
3.321 of 5 stars
$0.32
+1.0%
$2.00
+532.9%
-80.8%$37.59M$458.51MN/A1,040
ABT
Abbott Laboratories
4.9802 of 5 stars
$90.03
+2.5%
$118.30
+31.4%
-30.0%$156.77B$44.33B25.21115,000
ISRG
Intuitive Surgical
4.3271 of 5 stars
$403.04
+0.0%
$573.42
+42.3%
-24.2%$142.77B$10.06B48.8617,021
SYK
Stryker
4.926 of 5 stars
$310.58
+1.9%
$395.33
+27.3%
-15.6%$118.97B$25.27B35.9256,000

Related Companies and Tools


This page (NASDAQ:RMTI) was last updated on 6/29/2026 by MarketBeat.com Staff.
From Our Partners